Carotid stenting: Minimizing complications and maximizing benefit

Journal of Interventional Cardiology

Volumn 19, Issue SUPPL. 5, 2006, Pages

  Rajagopal, Vivek ^a   Yadav, Jay S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

AORTA ARCH; ARTERY BLOOD FLOW; ARTERY CALCIFICATION; ARTERY CATHETER; ARTERY DILATATION; ARTERY EMBOLISM; BLOOD PRESSURE REGULATION; CAROTID ARTERY; CAROTID ARTERY DISEASE; CARTOID ATHEROSCLEROSIS; CATHETER COMPLICATION; COMMON CAROTID ARTERY; COW; EXTERNAL CAROTID ARTERY; FILTER; HEART DISEASE; HEART PERFUSION; HIGH RISK PATIENT; HUMAN; HYPERPERFUSION SYNDROME; INTERNAL CAROTID ARTERY; NEUROIMAGING; PATIENT ASSESSMENT; PATIENT CARE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTIVE EQUIPMENT; REVIEW; STENT; SYNDROME; VASCULAR ACCESS;

EID: 33749020007     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2006.00178.x     Document Type: Review

References (11)

1. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493-1501.
2. von Beckerath N, Taubert D, Pogatsa-Murray G, et al. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: Results of the ISAR-CHOICE (intracoronary stenting and antithrombotic regimen: Choose between 3 high oral doses for immediate clopidogrel effect) trial. Circulation 2005;112:2946-2950.
3. Patti G, Colonna G, Pasceri V, et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) study. Circulation 2005;111:2099-2106.
4. Kastrup A, Groschel K, Krapf H, et al. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: A systematic review of the literature. Stroke 2003;34:813-819.
5. Aronow HD, Yadav JS. Embolic protection for carotid artery stenting - a 'no brainer.' Acta Chir Belg 2004;104:65-70.
6. Wholey MH Al-Mubarek N. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 2003;60:259-266.
7. Yen MH, Lee DS, Kapadia S, et al. Symptomatic patients have similar outcomes compared with asymptomatic patients after carotid artery stenting with emboli protection. Am J Cardiol 2005;95:297-300.
8. Yadav JS, Roubin GS, Iyer S, et al. Elective stenting of the extracranial carotid arteries. Circulation 1997;95:376-381.
9. Casserly IP, Abou-Chebl A, Fathi RB, et al. Slow-flow phenomenon during carotid artery intervention with embolic protection devices: Predictors and clinical outcome. J Am Coll Cardiol 2005;46:1466-1472.
10. Yadav JS. Embolic protection devices: Methods, techniques, and data. Tech Vasc Interv Radiol 2004;7:190-193.
11. Abou-Chebl A, Yadav JS, Reginelli JP, et al. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: Risk factors, prevention, and treatment. J Am Coll Cardiol 2004;43:1596-1601.